DrugPatentWatch Database Preview
Shilpa Company Profile
» See Plans and Pricing
What is the competitive landscape for SHILPA, and when can generic versions of SHILPA drugs launch?
SHILPA has eleven approved drugs.
There are four US patents protecting SHILPA drugs. There is one tentative approval on SHILPA drugs.
There are fifty-two patent family members on SHILPA drugs in twenty-five countries and twenty-nine supplementary protection certificates in eleven countries.
Summary for Shilpa
| International Patents: | 52 |
| US Patents: | 4 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 11 |
| Patent Litigation for Shilpa: | See patent lawsuits for Shilpa |
Drugs and US Patents for Shilpa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shilpa | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 207575-001 | Feb 22, 2019 | AP | RX | No | No | Get Started for $10 | Get Started for $10 | ||||
| Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-003 | Dec 22, 2015 | AP | RX | No | No | 8,940,786 | Get Started for $10 | Y | Get Started for $10 | ||
| Shilpa | IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 208302-002 | Jan 17, 2019 | AB | RX | No | No | Get Started for $10 | Get Started for $10 | ||||
| Shilpa | CAPECITABINE | capecitabine | TABLET;ORAL | 207456-002 | Dec 12, 2016 | AB | RX | No | No | Get Started for $10 | Get Started for $10 | ||||
| Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-001 | Dec 22, 2015 | AP | RX | No | No | 10,842,770 | Get Started for $10 | Y | Get Started for $10 | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Shilpa Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2885930 | Get Started for $10 |
| Eurasian Patent Organization | 027666 | Get Started for $10 |
| Canada | 2798180 | Get Started for $10 |
| South Korea | 20150066542 | Get Started for $10 |
| European Patent Office | 2566474 | Get Started for $10 |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shilpa Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0316704 | SPC/GB01/015 | United Kingdom | Get Started for $10 | PRODUCT NAME: CAPECITABINE AND HYDRATES AND SOLVATES THEREOF; REGISTERED: CH 54657 19980610; UK EU/1/00/163/001-002 20010202 |
| 0122707 | 96C0030 | Belgium | Get Started for $10 | PRODUCT NAME: CHLORHYDRATE DE GEMCITABINE EQUIVALENT EN GEMCITABINE; NAT. REGISTRATION NO/DATE: 58 IS 88 F 12 19960606; FIRST REGISTRATION: NL RVG 17854 19950327 |
| 0316704 | 2001C/021 | Belgium | Get Started for $10 | PRODUCT NAME: CAPECITABINE, NATL REGISTRATION NO/DATE: EU/1/00/163/001 20010205; FIRST REGISTRATION: CH 54657 19980610 |
| 1746976 | 17C1027 | France | Get Started for $10 | PRODUCT NAME: SEL DE SUCROSOFATE D'IRINOTECAN; REGISTRATION NO/DATE: EU/1/16/1130 20161018 |
| 0564409 | SPC/GB02/016 | United Kingdom | Get Started for $10 | PRODUCT NAME: IMATINIB (INN I.E. NON INTELLECTUAL PROPRIETARY NAME) OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS, ESPECIALLY THE MONOMETHANESULFONATE SALT; REGISTERED: CH IKS-NR: 55807 20010621; UK SG(2001) D/292083 20011108 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
